Medius Holdings Co., Ltd. (TYO:3154)
981.00
+11.00 (1.13%)
Apr 28, 2025, 3:30 PM JST
Medius Holdings Revenue
Medius Holdings had revenue of 73.55B JPY in the quarter ending December 31, 2024, with 10.50% growth. This brings the company's revenue in the last twelve months to 275.78B, up 11.44% year-over-year. In the fiscal year ending June 30, 2024, Medius Holdings had annual revenue of 259.79B with 8.67% growth.
Revenue (ttm)
275.78B
Revenue Growth
+11.44%
P/S Ratio
0.08
Revenue / Employee
109.57M
Employees
2,517
Market Cap
21.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 259.79B | 20.74B | 8.67% |
Jun 30, 2023 | 239.05B | 12.45B | 5.49% |
Jun 30, 2022 | 226.61B | -20.18B | -8.18% |
Jun 30, 2021 | 246.79B | 36.40B | 17.30% |
Jun 30, 2020 | 210.39B | 12.70B | 6.42% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,579.02B |
HOYA Corporation | 838.60B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,912.32B |
Olympus | 993.33B |